This Solicitation opportunity from Michigan was posted on February 9, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Over the counter opioid reversal nasal spray
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Michigan Department of Health and Human Services has issued a request for proposals to procure over-the-counter opioid reversal nasal sprays aimed at reducing opioid overdose fatalities within the state. The solicitation, posted on February 9, 2024, with a deadline for responses on February 29, 2024, seeks bids for a product that has gained FDA approval as of March 2023, allowing for nonprescription use. This initiative aligns with Michigan’s broader strategy to combat prescription drug and opioid abuse, as outlined in their comprehensive opioid remediation plan detailed in Exhibit E. The contract, managed by Kalamazoo RESA, falls under NAICS code 562910, which pertains to environmental and other waste management services, indicating a focus on public health and safety measures. The procurement emphasizes increasing access to life-saving naloxone, a medication proven to reverse opioid overdoses, with the goal of expanding availability to at-risk populations across Michigan. The primary contact for this solicitation is Katie Mcfarland, reachable via email or phone, and interested bidders can access additional details through the provided online portal. The contract underscores Michigan’s commitment to addressing the opioid crisis through strategic procurement and enhanced access to overdose reversal medications.
General Info
Agency
Place of Performance
MI, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This RFP is to solicit bids for over-the-counter (OTC) opioid reversal nasal spray to combat opioid overdoses in Michigan.
The Michigan Department of Health and Human Services (MDHHS) has taken action to prevent prescription drug and opioid abuse deaths and increase access to treatment for people with an opioid use disorder. Refer to Exhibit E - List of Opioid Remediation Uses for a comprehensive list of core strategies to be administered. MDHHS has been purchasing Naloxone which is a life-saving medication used to reverse the side effects of an opioid overdose. In March 2023, the FDA approved the first OTC, nonprescription, naloxone hydrochloride nasal spray for nonprescription use.
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
